Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 5, 1997JNCI Journal of the National Cancer InstituteOpen Access

Enhancing Efficacy of Recombinant Anticancer Vaccines With Prime/Boost Regimens That Use Two Different Vectors

View Full Paper
Ask AI
Bookmark
Share

Authors

KIKari R. IrvineNational Institutes of HealthRCRonald S. ChamberlainRutgers, The State University of New JerseyESEliza ShulmanNational Institutes of Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Irvine et al. (1997) studied this question.

synapsesocial.com/papers/6a19b8f91d4d911c80ea8a30https://doi.org/10.1093/jnci/89.21.1595
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine1992 · 211 citations
  2. 2Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen1995 · 83 citations
  3. 3Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells.1993 · 140 citations
  4. 4Characterization ofin VivoPrimary and Secondary CD8+T Cell Responses Induced by Recombinant Influenza and Vaccinia Viruses1996 · 92 citations
  5. 5Direct Gene Transfer into Mouse Muscle in Vivo1990 · 4,195 citations